Trial Profile
A retrospective study assessing the efficacy and safety of Secukinumab in patients with moderate to severe psoriasis in routine clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2017 New trial record